Three major science advancements on one day

AI discovers millions of crystal structures; breakthrough in 3D AI chips; UK Biobank's largest genome release for research

In a surprising coincidence, we've got three major science advancements on one day. Enjoy!

Today ChatGPT read 1246 top news stories. After removing previously covered events, there are 3 articles with a significance score over 7.

[7.5] AI discovers 2.2 million crystal structures, revolutionizing material science — Financial Times [$]

Google DeepMind's AI tool, GNoME, discovered 2.2 million theoretical crystal structures, far surpassing the previous record of 48,000 known stable materials, which included about 28,000 discovered in the past decade. This discovery equates to almost 800 years of material science progress. In a practical application, an autonomous laboratory, A-lab, used AI to successfully synthesize 41 out of 58 targeted novel compounds, achieving a success rate of over 70%. This breakthrough demonstrates AI's potential to significantly accelerate material science and technological advancements.

[7.5] 2D material reshapes 3D electronics for AI hardware — Washington University in St. Louis

A team of international researchers published a breakthrough in computer chip technology in Nature Materials. They developed a monolithic 3D-integrated chip using six atomically thin 2D layers, each serving a unique function. This innovation significantly reduces processing time, power consumption, latency, and physical footprint, enhancing AI computing efficiency. The technology promises to revolutionize multifunctional computing hardware, potentially impacting a wide range of applications from autonomous vehicles to medical diagnostics.

[7.2] UK Biobank releases whole-genome sequences for research — The Guardian

UK Biobank has released the whole genomes of 500,000 individuals for global medical research, marking the largest such release to date. This expansive genetic data, paired with comprehensive health records, aims to advance understanding and treatment of diseases like cancer, heart disease, and genetic conditions. Researchers will explore gene variants linked to diseases and lifestyle factors, potentially leading to personalized risk assessments and new drug targets. Previously, only 1% of the DNA from UK Biobank volunteers was available for study. This significant scale-up is expected to uncover rarer genetic drivers of diseases.

Want to read more?

See additional news on

Thanks for reading us and see you tomorrow,